GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Renascience Inc (TSE:4889) » Definitions » Construction In Progress

Renascience (TSE:4889) Construction In Progress : 円0.0 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Renascience Construction In Progress?


Renascience Construction In Progress Historical Data

The historical data trend for Renascience's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renascience Construction In Progress Chart

Renascience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Construction In Progress
- - - - -

Renascience Quarterly Data
Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Renascience Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Renascience Business Description

Traded in Other Exchanges
N/A
Address
2-3-6 Nihombashi-Honcho, Chuo-ku, Tokyo, JPN, 103-0023
Renascience Inc is engaged in the research and development of new medical solutions by utilizing various modalities such as pharmaceuticals, medical devices, artificial intelligence and others to solve problems in the medical setting.

Renascience Headlines

No Headlines